ThreeD Capital

Founded in 1987, ThreeD Capital is a Toronto-based venture capital firm investing in early-stage companies across various sectors including technology (AI, blockchain, IoT), electric vehicles, and junior resources.

Sheldon Inwentash JD

Chairman, CEO and CIO

5 past transactions

Tenet

Post in 2025
Tenet Fintech Group, through its subsidiary Peak Positioning Corporation, operates as a software developer focused on mobile computing devices, primarily in China and North America. The company offers HomeWave, a proactive security solution that enables corporate IT departments to connect wirelessly with mobile devices that have been reported missing, thereby preventing unauthorized access to data. Additionally, Tenet Fintech Group provides a range of applications designed for mobile devices, including cloud-based email, calendar synchronization, and automated device configuration. Headquartered in Montréal, Canada, Tenet aims to enhance security and functionality for mobile users and organizations.

Infinitii Ai

Post in 2023
Infinitii Ai specializes in environmental monitoring for water infrastructure utilities across the U.S. and Canada. The company offers AI-driven predictive analytics software designed to analyze time-series data, enabling real-time analysis, alarm setting, and predictive machine learning insights.

Turn.bio

Venture Round in 2022
Turn.bio is a biotechnology company developing drugs to reverse aging and age-related diseases. Utilizing its patented mRNA platform technology ERA, the company targets indications in immune-related diseases like cancer and dermatological conditions, as well as therapies for ophthalmology, osteoarthritis, and the muscular system.

XREX

Seed Round in 2021
XREX is a blockchain-based financial institution offering secure crypto exchange services, escrow services for global transactions, and fiat-to-crypto transactions.

Wuhan General Group

Post in 2020
Wuhan General Group, through its subsidiaries, is a biotechnology company headquartered in Pointe-Claire, Canada, specializing in the research, development, and commercialization of cannabidiol (CBD) and psilocybin-based products. The company markets its offerings under various brands, including Dr. AnnaRx, Medspresso, and Handcrafted Delights, targeting medical applications for conditions such as cancer, chronic pain, and mental disorders. Additionally, Wuhan General Group is engaged in exploring new therapies involving psilocybin, with a focus on addressing mental health issues, alcohol addiction, and related health concerns.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.